From left, Spectral MD CEO and Co-Founder Wensheng Fan and General Counsel Vince Capone. [Photos: Spectral MD]
With $130 million in government funding supporting its AI-powered wound-prediction tech as a triage tool for burn victims in a mass casualty event, Dallas-based Spectral MD is nearing its listing on Nasdaq via a SPAC merger. Its listing as "Spectral AI" is slated for September 8 or 11, and the company offered updates on how it's going—revealing the nuts & bolts of how such transactions work.